US25659T1079
US25659T1079
Dolby Laboratories
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.5B EUR | 4.92B EUR | 5.68B EUR | 6.14B EUR |
Enterprise Value | 4.86B EUR | 4.3B EUR | 5.14B EUR | 5.53B EUR |
Valuation Multiples | ||||
Trailing P/E | 25x | 21.77x | 23.32x | 41.25x |
Forward P/E | 12.83x | -- | -- | -- |
Price to Sales | 4.06x | 3.64x | 4.16x | 6.33x |
Price to Book | 2.13x | 1.91x | 2.17x | 2.37x |
EV/Revenue | 3.59x | 3.18x | 3.76x | 5.71x |
EV/EBITDA | 13.71x | 11.09x | 13.12x | 22.36x |
Price to FCF (P/FCF) | 16.58x | 14.29x | 22.01x | 28.98x |
EV/FCF | 14.65x | 12.49x | 19.9x | 26.13x |
FCF Yield | 6.03% | 7% | 4.54% | 3.45% |